|
Market Cap (4-Jul) $77,044,616 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (19-Jun) 12,988,365 (0.64%) (278th) |
|
52w High $0.073 |
52w Low $0.026 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 24 August 2021, 10:46. The announcement is marked as price sensitive, and is 2 page(s) in length and 247.96kb in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 1.322% short sold according to ASIC data. It was ranked the 140th most shorted stock on the ASX. It remains ranked 278th as of the latest reported data (19 June 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| Receipt of $1.8 Million R&D Tax Incentive Refund | 24 August 2021, 10:46 |
| FDA Grants Breakthrough Device Designation for Renal Failure | 23 August 2021, 8:18 |
| Application for quotation of securities - IPD | 9 August 2021, 8:14 |
| Appendix 4C & Quarterly Activities Report | 27 July 2021, 8:22 |
You must be logged in to post a reply.
ImpediMed 